Synvista Therapeutics Inc (SYNI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0001 unch (unch) 02/20/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0001 unch (unch) -
for Thu, Feb 20th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2017 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
Cash Flows From Operating Activities | |||||
Net Income | N/A | -16,090 | -17,670 | -12,610 | -13,950 |
Depreciation Amortization | N/A | 6,470 | 40 | 60 | 70 |
Other Working Capital | N/A | 1,070 | -1,270 | -1,510 | 790 |
Other Operating Activity | 0 | 610 | 11,470 | 30 | -20 |
Operating Cash Flow | $N/A | $-7,940 | $-7,430 | $-14,030 | $-13,110 |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | -10 | 0 | -10 | -20 |
Net Acquisitions | N/A | 0 | -1,620 | 0 | 0 |
Other Investing Activity | 0 | -400 | 150 | -80 | 40 |
Investing Cash Flow | $N/A | $-410 | $-1,470 | $-90 | $20 |
Cash Flows From Financing Activities | |||||
Other Financing Activity | 0 | 22,530 | 3,800 | 9,530 | 7,580 |
Financing Cash Flow | $N/A | $22,530 | $3,800 | $9,530 | $7,580 |
Beginning Cash Position | N/A | 1,470 | 6,580 | 11,170 | 16,670 |
End Cash Position | N/A | 15,640 | 1,470 | 6,580 | 11,170 |
Net Cash Flow | $N/A | $14,160 | $-5,100 | $-4,590 | $-5,500 |
Free Cash Flow | |||||
Operating Cash Flow | N/A | -7,940 | -7,430 | -14,030 | -13,110 |
Free Cash Flow | 0 | -7,940 | -7,430 | -14,030 | -13,110 |